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    There are different complex anatomical structures in the shoulder and axillary regions, many of which can give rise to 
neoplasms. Lymphomas with the involvement of soft tissues as a primary event are very rare. The published studies have a small sample size, most of them as case 
reports. We want to highlight and draw attention to  the clinicians,  surgeons,  pathologists and all the doctors to pick up  this pathology in the differential diagnosis in a 
tumor which is first suspected to be a soft tissue sarcoma.  We report a rare case of shoulder pain in a patient affected by a Diffuse Large B-Cell Lymphoma (DLBCL), 
of the left  shoulder, his follow-up and a review literature  of the shoulder lymphoma. 
 
 Introduction 
 Even though most shoulder affections are diagnosed by history, physical examination, and radiographic imaging, diffuse 
neoplasms of this area may be better assessed at histopathology(1). Among these latter, the non-Hodgkin lymphoma (NHL) is one 
of the most common, especially the diffuse large B cell lymphoma (DLBCL). The incidence of NHL is increasing, accounting for 
40,000 cases per year in the United States(2), mostly in patients with acquired immunodeficiency or taking immunosuppressive 
drugs. Often lethal, it usually occurs with multiple lymphadenopathies, but any site containing lymphoid tissue, included the bone 
marrow, may be involved. The involvement of soft tissues is primary in less than 1%(3) and, when present, is usually secondary to 
a direct spreading from affected surrounding lymphoidal sites and/or metastatic hematogenous dissemination (4). From a clinical 
point of view, lymphomas usually manifest with a soft tissue mass, swelling, and pain. Most patients are asymptomatic whereas the 
main presentation is a painless adenopathy in the neck or supraclavicular regjion (5).  
 Soft tissue sarcomas and lymphomas are among the malignant neoplasms which can be seen in these regions. 
Differentiation between these tumour types is based on clinical findings, radiological features, and especially in  histopathologic 
examination. The histopathological distinction between lymphoma and soft tissue sarcoma is routinely determined by IHC. There is 
a large panel of immunohistochemichal markers like: Leucocyte common antigen (LCA) (lymphoid marker), CD3, CD20 and 
vimentin (mesenchymal marker), which  are commonly used for this purpose.  
 Case Report 
 In  August  2013, in our hospital, a 42-years old man  presented with diffuse left shoulder mass, it has been present for 
two years with progressive enlargement,which was associated with continuous pain and difficulty in the movement of the left 
scapulo-humeral articulation. He denied any constitutional symptoms, including weight loss, fever, or night sweats. On physic 
examination the mass was poorly defined with a smooth outer surface,and according to these data, clinically a sarcoma of soft 
tissue was suspected. Clinico-biochemical analysis was in norme also tumoral markers. (HCG<2mIU/ml, AFP-0, 6UI/ml, CEA-0,5 
µg/L). CT-scan and MRI revealed a diffuse infiltrative tumour mass involving left shoulder musculatures.Figure 1(a,b,c,d). 
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Figure 1c                                                                         Figure 1d 
 
Figure 1(a,b,c,d)-MRI and CT scan show a diffuse soft tissue mass involving the left  shoulder musculatures,but without involvement of left lung. 
 
 In this condition, with the consent of the patient  an incisional biopsy of the mass  was performed. Microscopic 
examination showed diffuse cell infiltration with big round nucleus,with evident nucleolus and frequent mitosis. 
Immunohistochemystry performed showed: CD45(+), CD20(+), CD79a(+), CD3(-), CD23(-), CD30(-), Bc-2(-), Bcl-6(-), Bcl-1(-), 
TdT(-), Vimentine(-) and Ki-67 65-70%, which are consistent with: Diffuse large B cell lymphoma. 
 
 The patients has done 9 cycle of chemotherapy (CHOP+Rituximab) after 8 months (April 2014) he comes again to the 
hospital with a huge mass in the same location. The patient has limitation of movement in scapulohumeral articulation, large pain, 
edema and echimotic changes of the skin above the tumor as in (the figure 2) below: 
         
Figure 2:After second  en bloc resection of the tumour  surgery with some large diffuse soft masess,where the biggest one is 15*10 cm. 
 
Immune-histochemistry of paraffin sections showed positive  membranous immunoreactivity in CD79a(+), Bcl-6(+), Bcl-2(-), 
CD3(+), CD5(+), CD10(-), CD23(-), Vimentine(-) in stromal cells, but negative in neoplastic cells, which exclude mesenchimal 
histogenesis (Figure3). 
 
 Most important findings was CD20(-), which is  connected with ANTI-CD20-Therapy.So this findings were  consistent 
with Diffuse Large B Cell Lymphoma. 
    
a b
A 
Page | 48  
 Volume 4, issue 1, 2015  e-ISSN: 1857-8187   p-ISSN: 1857-8179                                                                                                                      Case Study 
 Anglisticum Journal (IJLLIS), Volume: 4 | Issue: 1, January 2015 |  
 
        
Figure 3 Hematoxylin and eosin (a, b) staining of the lesion and some immunostaining images (c-e). 
Shown are immunostatining examples of CD79a (c), CD20 (d), Ki-67(e). 
 
He underwent again chemotherapy 5 cycle.In September 2014 he complains physical weaknees,fatigue,pale mucosae and 
skin,thoracal discomfort,anorexia, and bleeding from the mass..The inspection of the scapulohumeral articulation revealed 
laceration and destruction of the skin and all surrounding soft tissues around scapulohumeral articulation and scapula,accompanied 
with hemorrhagic changes,as in (the figure 4) below:  
                  
      Figure 4  Fig.4a before operation                                      Fig.4b Specimen                                        Fig.4c after operation 
 
Second surgery was performed were is observed including of glenoidal capsula. To date the patient is following chemotherapy and 
his physical condition is not so good. 
 
 Discussion 
 DLBCL is a group of large, lymphoid B-cell malignant proliferations that is clinically, morphologically, and genetically 
heterogenous. It constitutes about 30% of all non-Hodgkin lymphomas and is the most common histologic subtype(6). A shoulder 
lymphoma has to be differentiated from neoplasms involving the soft tissue, mostly the sarcoma, osteomielitis, spine affections, 
and neurological disorders. The case reported here was initially considered rhabdomyosarcoma, because of the morphologic 
features, the patient’s age and the location of the tumor. MRI is more specific to assess the extent of the mass within the bone and 
surrounding soft tissues. The initial diagnosis was ruled out by immunohistochemical analysis that showed that tumor cells were 
positive for CD20, CD45 and negative for vimentine. This is the primary  case of Diffuse Large B cell-lymphoma of the shoulder 
occurring with isolated pain and limited range of motion of the left  shoulder in an Albanian  patient without any associated 
immunological disorder.  Lymphoma may also be associated with lupus erythematosus(7), scleroderma, and Sjögren’s syndrome. 
In addition, prolonged immunosuppressive therapies may increase the risk for neoplasms of the immune system(8).  
 The malignancy’s stage and histopathological diagnosis have a major impact on its treatment and prognosis. Patients with 
lymphoma are usually treated with chemotherapy or local irradiation. Up to now, there a few cases repoted in the literature. So, in a 
study of 79 cases od DLBCL of primary cutaneous resulted 3 cases on the chest, 2 cases on the shoulder, 2 cases on the back, 1 
case on the trunk, and others on the extremities (9). Another case of shoulder lymphoma has been found in a patient who had 
undergone shoulder arthroplasty after prolonged immunosuppressive therapy taken because affected by long-standing rheumatoid 
arthritis (10). A case of DLBCL of shoulder  is reported in a 34 year-old lady, also treated for HIV infection(11). In the few 
reported cases of DLBCL of the chest wall, surgery provided a relatively satisfactory outcome. Luh et al (12), reported a patient 
with DLBCL developing from a long-standing pyothorax of the left lower chest wall. In that case, the patient remained free of local 
recurrence or metastasis at nine months after surgical resection, without further chemotherapy (13). In Hsu et al.’s series (14), 3 of 
the 4 patients with isolated chest wall lymphoma were managed with surgical resection and adjuvant chemotherapy. In our case the 
first management of this condition was surgery and after  surgery, the patient started chemotherapy CHOP (cyclophosphamide, 
doxorubicin, vincristine, and prednisone, rituximab), but the mass was excessive. Our patient’s staging included an abdominal and 
brain CT scan, which gave no indication of metastasis. Surgery in soft tissue lymphoma is still controversial. Damron et al. (15) are 
convinced that lymphoma is a non surgical disease in which chemotherapy and/or radiotherapy are adequate therapeutic strategies 
and they do not recommend the surgical excision since it would remove a clinical barometer of responsiveness to medical 
treatment. Biopsy should be only performed to confirm the nature of the lesion, especially in differential diagnosis with soft tissue 
sarcoma.  On the contrary Bozas et al (16), described a case of abdominal wall mass (10×18cm) situated between the abdominal 
muscles and in which a wide excision was performed followed by immuno-chemotherapy. Belaabidia et al. (17), also described a 
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case of muscle lymphoma of biceps femoris (17×14×7cm) in which treatment was wide surgery followed by chemotherapy. In our 
patient we have applied surgery as a palliative treatment. 
 
 Conclusion 
 A painful shoulder may be cause not only from sarcoma, but also from lymphoma. In suspected patients, plain 
radiographs should be followed by magnetic resonance imaging and biopsy to determine the right  diagnosis and treatment. The 
malignancy’s stage and histopathological diagnosis have a major impact on its treatment and prognosis. Patients with lymphoma 
are usually treated with chemotherapy. This report does not allow to draw any conclusion about the best treatment and long term 
outcomes of DLBCL  patients. Larger studies with long-term follow-ups are needed to better define the evolution of this pathology. 
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